DOI:
10.1055/s-00029030
Journal of Pediatric Neurology
LinksClose Window
References
Ranieri C, Di Tommaso S, Loconte DC. et al.
In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS).
Neurogenetics 2018;
19 (02) 77-91
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.